The global endoscopic retrograde cholangiopancreatography market is projected to reach USD 2.0 billion by 2026 , at a CAGR of 9.6%


Posted May 13, 2022 by snehalshaha

The global endoscopic retrograde cholangiopancreatography market is projected to reach USD 2.0 billion by 2026 from USD 1.3 billion in 2021, at a CAGR of 9.6% during the forecast period.
 
The growth of endoscopic retrograde cholangiopancreatography market is majorly attributed to factors such as the rising incidence of cancer, increasing investments by governments and healthcare organizations to improve endoscopy research, growing focus on investments by hospitals for advanced endoscopy instruments, and the increasing preference for minimally invasive surgeries. On the other hand, the high costs of endoscopic retrograde cholangiopancreatography devices, the development of other procedures like EUS and MRCP, and the shortage of trained physicians and endoscopists are factors expected to restrain the market growth to a certain extent.
The global endoscopic retrograde cholangiopancreatography market is projected to reach USD 2.0 billion by 2026 from USD 1.3 billion in 2021, at a CAGR of 9.6% during the forecast period.
Download PDF Brochure: -https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=170242954
Market Segmentation :-
The endoscopic retrograde cholangiopancreatography market has been segmented on the basis of product, procedure, end user, and region. Based on products, the endoscopic retrograde cholangiopancreatography market has been segmented into endoscopes, endotherapy devices, visualization systems, energy devices, and others. The factors attributing to the large revenue of the endotherapy devices segment include the growing preference for minimally invasive surgeries and the increasing prevalence of gastrointestinal conditions.
In the endotherapy devices segment, sphincterotomes accounted for the largest market share during the forecast period. This can be attributed to the increasing incidence of pancreatic duct and bile duct stones and the growing geriatric population leading to an increase in biliary disorders.
North America accounted for the largest share of the Endoscopic retrograde cholangiopancreatography market in 2020. The increasing prevalence of cancer, high investments by hospitals to purchase new ERCP equipment, and a strong focus on research activities to improve endoscopy techniques are the major factor contributing to this.
Request Sample Pages: -https://www.marketsandmarkets.com/requestsampleNew.asp?id=170242954
Regional Analysis:-
The Asia Pacific and Latin American markets are projected to grow at the highest CAGR during the forecast period. The high growth in these regional markets can be attributed to the growing number of hospitals, improving healthcare infrastructure, rising healthcare expenditure, the growing patient population, surging demand for minimally invasive surgeries, and favorable government policies single-use endoscopy devices. Additionally, governments in several Latin American countries focus on improving their respective healthcare systems. The healthcare sector in Brazil has undergone significant changes, making the country one of the world's most promising and attractive markets.
-- END ---
Contact Email [email protected]
Issued By snehalshaha
Country United States
Categories Biotech , Business , Technology
Tags endoscopic retrograde cholangiopancreatography market
Last Updated May 13, 2022